Study: Crisan 2025, Nutrients
Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
Citation
Crisan D, Gavrilas L, Paltinean R, Frumuzachi O et al (2025). Nutrients. PubMed id 41305552.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Moringa: blood sugar, blood pressure and general health Tier B thin
B Adults in 9 randomised trials of Moringa oleifera (12 arms); countries not listed in the abstract (n=9 trials (341 intervention, 308 control))
Systematic review and meta-analysis of RCTs with GRADE.
Moringa showed no significant effects on most outcomes (weight, lipids, glycaemic indices). A modest fall in diastolic blood pressure was not robust in sensitivity analyses. The authors rated the certainty of evidence very low for all outcomes and say current evidence does not support consistent cardiometabolic benefits.
As recorded in this card: Crisan D, Gavrilas L, Paltinean R, Frumuzachi O et al (2025), Nutrients, [review]
Note: Participants' ancestry not stated; authors report no conflicts of interest.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.